PainReform to Present at the Maxim Group Virtual Healthcare

TEL AVIV, Israel, June 15, 2023 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of…

Source: www.globenewswire.com – Read more